What is the recommended dosage of propranolol (beta blocker) for daily migraine prevention?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Propranolol Dosing for Daily Migraine Prevention

For daily migraine prevention, start propranolol at 80 mg once daily and titrate up to a target range of 80-240 mg daily, with most patients achieving optimal control at 160 mg once daily. 1, 2, 3

Starting and Titration Strategy

  • Begin with 80 mg once daily as the standard initial dose for migraine prophylaxis 1, 3
  • Gradually increase the dose at 3-7 day intervals based on response and tolerability 3
  • The usual effective maintenance dose is 120-160 mg once daily, though some patients may require up to 240 mg daily 1, 3
  • An adequate trial requires 2-3 months at therapeutic dosing before determining treatment failure, as clinical benefits may not become apparent immediately 1, 4

Evidence Supporting Lower Doses

While guidelines recommend 80-240 mg daily, research suggests that many patients respond to lower doses:

  • 73.5% of patients responded to doses at or below 1 mg/kg body weight daily (approximately 40-80 mg for most adults), with fewer than one-third requiring higher doses 5
  • A study using 40 mg daily showed effectiveness when combined with other agents, though monotherapy at this dose had limited evidence 6
  • Starting low and titrating up minimizes side effects while identifying the minimum effective dose for each patient 1, 5

Patient Selection Criteria

Consider propranolol for patients who meet any of these criteria:

  • Two or more migraine attacks per month with disability lasting 3+ days per month 1, 2
  • Using acute rescue medications more than twice per week 1, 2
  • Failure of or contraindications to acute migraine treatments 1, 2
  • Pure migraine without tension-type features (propranolol is superior to amitriptyline in this population) 4

Monitoring and Side Effects

  • Common adverse effects include fatigue, depression, nausea, dizziness, and insomnia, though these are generally well-tolerated 1, 2
  • Monitor for mood changes (particularly depression) and sleep disturbances throughout treatment 1, 2
  • Routine cardiovascular monitoring (heart rate and blood pressure) is not required between appointments if the patient is well 1
  • The risk of discontinuation due to adverse events is low but increases with higher doses 5, 7

Critical Contraindications

Absolute contraindications include:

  • Bradycardia 1
  • Heart block 1

Important Pitfall to Avoid

Never use beta-blockers with intrinsic sympathomimetic activity (ISA) for migraine prevention, as they are ineffective 1, 2. Only propranolol and timolol have the strongest evidence for efficacy among beta-blockers 1, 2.

Treatment Duration and Discontinuation

  • After achieving a period of stability (usually 2-3 months), consider tapering or discontinuing the medication 2
  • Propranolol can be stopped abruptly rather than requiring gradual weaning, though gradual reduction over several weeks may be advisable depending on the patient's age, comorbidities, and dose 3
  • Continuous assessment of efficacy and side effects is recommended throughout treatment 1, 2

Comparative Effectiveness

  • Propranolol is superior for pure migraine, while amitriptyline may be better for mixed migraine and tension-type headache 1, 4
  • Propranolol has moderate certainty evidence for reducing monthly migraine days by approximately 1.27 days versus placebo 7
  • The number needed to treat for a 50% or more reduction in monthly migraine days is approximately 6 patients 7

References

Guideline

Propranolol Dosing for Migraine Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Migraine Prevention with Beta-Blockers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Preventative Treatments for Occipital Headaches

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The dose of propranolol for migraine prophylaxis. Efficacy of low doses.

Cephalalgia : an international journal of headache, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.